Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | General Counsel and CCO | $220K | Feb 1, 2024 | ||
NBRV | Nabriva Therapeutics plc | General Counsel and Corp Sec | Aug 11, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|